Use of hyaluronidase for preventing and treating cardio...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/47 (2006.01) A61K 31/205 (2006.01) A61K 33/06 (2006.01) A61K 45/06 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2411233

The invention relates to the use of the enzyme hyaluronidase in a dosage of at least 6000 units per day for preventing and/or treating cardiovascular diseases. The hyaluronidase is administrated intravenously over a period of at least four weeks. Hyaluronidase is especially suitable for treating coronary heart disease and for prevention in patients at risk of cardiac infarction.

L'invention concerne l'utilisation de l'enzyme hyaluronidase dans un dosage d'au moins 6000 unités par jour pour la prophylaxie ou le traitement de maladies cardio-vasculaires, l'hyaluronidase étant administrée par voie intraveineuse sur une période d'au moins 4 semaines. L'hyaluronidase convient notamment au traitement de la cardiopathie coronarienne, ainsi qu'à la prophylaxie chez des patients susceptibles de faire un infarctus du myocarde.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of hyaluronidase for preventing and treating cardio... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of hyaluronidase for preventing and treating cardio..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hyaluronidase for preventing and treating cardio... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1762555

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.